Furthermore, the DSS analyses revealed that Piezo2 acted as a protective factor in KIRC, and LUAD and a risk factor in KIRP and PAAD (Figures 6F–J). This evidence concerns the gene PIEZO2 and pancreatic adenocarcinoma.